Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins
Neel, Dana S, Allegakoen, David V, Olivas, Victor, Mayekar, Manasi K, Hemmati, Golzar, Chatterjee, Nilanjana, Blakely, Collin M, McCoach, Caroline E, Rotow, Julia K, Le, Anh, Karachaliou, Niki, Rosell, Rafael, Riess, Jonathan W, Nichols, Robert, Doebele, Robert C, Bivona, Trever G
Published in Cancer research (Chicago, Ill.) (01.02.2019)
Published in Cancer research (Chicago, Ill.) (01.02.2019)
Get full text
Journal Article
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study
Ji, Jingran, Aredo, Jacqueline V., Piper-Vallillo, Andrew, Huppert, Laura, Rotow, Julia K., Husain, Hatim, Stewart, Susan, Cobb, Rosemary, Wakelee, Heather A., Blakely, Collin M., Wong, Melisa L., Gubens, Matthew A., Madani, Mohammad H., Digumarthy, Subba R., McCoach, Caroline, Piotrowska, Zofia, Neal, Joel W., Riess, Jonathan W.
Published in JTO clinical and research reports (01.03.2023)
Published in JTO clinical and research reports (01.03.2023)
Get full text
Journal Article
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
Piper-Vallillo, A.J., Rotow, Julia K., Aredo, Jacqueline V., Shaverdashvili, Khvaramze, Luo, Jia, Carlisle, Jennifer W., Husain, Hatim, Muzikansky, Alona, Heist, Rebecca S., Rangachari, Deepa, Ramalingam, Suresh S., Wakelee, Heather A., Yu, Helena A., Sequist, Lecia V., Bauml, Joshua M., Neal, Joel W., Piotrowska, Zofia
Published in JTO clinical and research reports (01.06.2022)
Published in JTO clinical and research reports (01.06.2022)
Get full text
Journal Article
Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study
Banla, Leou Ismael, Tzeng, Alice, Baillieul, John P., Kandekhar, Melin J., Fitzgerald, Kelly J., LoPiccolo, Jaclyn, Poitras, Holly A., Soto, Dan E., Rotow, Julia K., Singer, Lisa, Willers, Henning, Kozono, David E., Janne, Pasi A., Mak, Raymond H., Piotrowska, Zofia, Keane, Florence K., Kann, Benjamin H.
Published in JTO clinical and research reports (01.10.2023)
Published in JTO clinical and research reports (01.10.2023)
Get full text
Journal Article
RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis
Oh, Juliana J, Taschereau, Eileen O, Koegel, Ashley K, Ginther, Charles L, Rotow, Julia K, Isfahani, Khadijeh Z, Slamon, Dennis J
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2010)
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2010)
Get full text
Journal Article
Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib
Rotow, Julia K, Lee, Jessica K, Madison, Russell W, Oxnard, Geoffrey R, Jänne, Pasi A, Schrock, Alexa B
Published in Journal of thoracic oncology (01.02.2024)
Published in Journal of thoracic oncology (01.02.2024)
Get full text
Journal Article
Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer
Sharp, John A, Jones, Daniel, Rotow, Julia K, Fidias, Panos M, Bertino, Erin, Owen, Dwight H
Published in Journal of the National Comprehensive Cancer Network (01.04.2024)
Published in Journal of the National Comprehensive Cancer Network (01.04.2024)
Get more information
Journal Article
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer
Rotow, Julia K, Gui, Philippe, Wu, Wei, Raymond, Victoria M, Lanman, Richard B, Kaye, Frederic J, Peled, Nir, Fece de la Cruz, Ferran, Nadres, Brandon, Corcoran, Ryan B, Yeh, Iwei, Bastian, Boris C, Starostik, Petr, Newsom, Kimberly, Olivas, Victor R, Wolff, Alexander M, Fraser, James S, Collisson, Eric A, McCoach, Caroline E, Camidge, D Ross, Pacheco, Jose, Bazhenova, Lyudmila, Li, Tianhong, Bivona, Trever G, Blakely, Collin M
Published in Clinical cancer research (15.01.2020)
Published in Clinical cancer research (15.01.2020)
Get full text
Journal Article
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study
Blakely, Collin M, Urisman, Anatoly, Gubens, Matthew A, Mulvey, Claire K, Allen, Greg M, Shiboski, Stephen C, Rotow, Julia K, Chakrabarti, Turja, Kerr, D Lucas, Aredo, Jacqueline V, Bacaltos, Bianca, Gee, Megan, Tan, Lisa, Jones, Kirk D, Devine, W Patrick, Doebele, Robert C, Aisner, Dara L, Patil, Tejas, Schenk, Erin L, Bivona, Trever G, Riess, Jonathan W, Coleman, Melissa, Kratz, Johannes R, Jablons, David M
Published in Journal of clinical oncology (10.09.2024)
Published in Journal of clinical oncology (10.09.2024)
Get full text
Journal Article
Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation
Rotow, Julia K., Woodard, Gavitt A., Urisman, Anatoly, McCoach, Caroline E., Bivona, Trever G., Elicker, Brett M., Jablons, David M., Blakely, Collin M.
Published in Clinical lung cancer (01.03.2019)
Published in Clinical lung cancer (01.03.2019)
Get full text
Journal Article
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
Maynard, Ashley, McCoach, Caroline E., Rotow, Julia K., Harris, Lincoln, Haderk, Franziska, Kerr, D. Lucas, Yu, Elizabeth A., Schenk, Erin L., Tan, Weilun, Zee, Alexander, Tan, Michelle, Gui, Philippe, Lea, Tasha, Wu, Wei, Urisman, Anatoly, Jones, Kirk, Sit, Rene, Kolli, Pallav K., Seeley, Eric, Gesthalter, Yaron, Le, Daniel D., Yamauchi, Kevin A., Naeger, David M., Bandyopadhyay, Sourav, Shah, Khyati, Cech, Lauren, Thomas, Nicholas J., Gupta, Anshal, Gonzalez, Mayra, Do, Hien, Tan, Lisa, Bacaltos, Bianca, Gomez-Sjoberg, Rafael, Gubens, Matthew, Jahan, Thierry, Kratz, Johannes R., Jablons, David, Neff, Norma, Doebele, Robert C., Weissman, Jonathan, Blakely, Collin M., Darmanis, Spyros, Bivona, Trever G.
Published in Cell (03.09.2020)
Published in Cell (03.09.2020)
Get full text
Journal Article
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET -altered solid tumors
Cooper, Alissa Jamie, Drilon, Alexander E., Rotow, Julia K., Liu, Stephen V., Gautschi, Oliver, Smith, Katherine Emilie Rhoades, Lee, Dae Ho, Nagasaka, Misako, Loong, Herbert H. F., Pennell, Nathan A., Patel, Jyoti D., Früh, Martin, Solomon, Benjamin J., Pall, Georg, Uy, Natalie F., Riess, Jonathan W., Wirth, Lori J., Yeap, Beow Y., Gainor, Justin F., Lin, Jessica Jiyeong
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
BLU-945 monotherapy and in combination with osimertinib (OSI) in previously treated patients with advanced EGFR -mutant ( EGFRm ) NSCLC in the phase 1/2 SYMPHONY study
Elamin, Yasir Y, Nagasaka, Misako, Shum, Elaine, Bazhenova, Lyudmila, Camidge, D. Ross, Cho, Byoung Chul, Felip, Enriqueta, Goto, Koichi, Lin, Chia-Chi, Piotrowska, Zofia, Planchard, David, Rotow, Julia K., Spigel, David R., Tan, Daniel Shao-Weng, Yoshida, Tatsuya, Minchom, Anna Rachel, De Langen, Adrianus, Kato, Terufumi, Zalutskaya, Alena, Reckamp, Karen L.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR -mutated non-small cell lung cancer
Aredo, Jacqueline V., Urisman, Anatoly, Gubens, Matthew A., Mulvey, Claire, Allen, Greg M., Rotow, Julia K., Kerr, Daniel Lucas, Chakrabarti, Turja, Bacaltos, Bianca, Gee, Megan, Jones, Kirk, Aisner, Dara L., Patil, Tejas, Schenk, Erin Lynn, Bivona, Trever G., Riess, Jonathan W., Coleman, Melissa, Kratz, Johannes Ruediger, Jablons, David, Blakely, Collin M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase 1/2 study of BLU-945 in patients with common activating EGFR -mutant non–small cell lung cancer (NSCLC): SYMPHONY trial in progress
Shum, Elaine, Elamin, Yasir Y, Piotrowska, Zofia, Spigel, David R, Reckamp, Karen L., Rotow, Julia K, Tan, Daniel Shao-Weng, Lim, Sun Min, Kim, Tae Min, Lin, Chia-Chi, Kato, Terufumi, Parepally, Jagan, Albayya, Faris, Louie-Gao, Melinda, Weinig, Tessa, Zalutskaya, Alena, Goto, Koichi
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase 1/2 study of the highly selective EGFR inhibitor, BLU-701, in patients with EGFR -mutant non–small cell lung cancer (NSCLC)
Spira, Alexander I., Spigel, David R., Camidge, D. Ross, De Langen, Adrianus, Kim, Tae Min, Goto, Koichi, Elamin, Yasir Y, Shum, Elaine, Reckamp, Karen L., Rotow, Julia K, Goldberg, Sarah B., Gadgeel, Shirish M., Leal, Ticiana, Albayya, Faris, Fitzpatrick, Sarah, Louie-Gao, Melinda, Parepally, Jagan, Zalutskaya, Alena, Yu, Helena Alexandra
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A first-in-human phase 1 study of the next-generation RET inhibitor, LOXO-260, in RET inhibitor refractory patients with RET-altered cancers (trial in progress)
Pennell, Nathan A., Wirth, Lori J., Gainor, Justin F., Rotow, Julia K, Johnson, Melissa Lynne, Bauer, Todd Michael, Kroiss, Matthias, Sukrithan, Vineeth, Kang, Hyunseok, Worden, Francis P., Bestvina, Christine M., Hadoux, Julien, Cassier, Philippe Alexandre, Italiano, Antoine, Wolf, Juergen, Brose, Marcia S., Avsar, Emin, Axelson, Michael D., Subbiah, Vivek, Drilon, Alexander E.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article